Taysha Gene Therapies (TSHA) Earnings Date & Reports
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TSHA is expected to report earnings to -8 cents per share on August 18
Q2'25
Est.
$-0.08
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.07
The last earnings report on May 15 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 3.57M shares outstanding, the current market capitalization sits at 751.90M.